| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-08 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |